CVAC logo

CureVac NV (CVAC) EBITDA

Annual EBITDA

-$253.43 M
-$19.62 M-8.39%

December 31, 2023

Summary

Performance

1-Year Change

-8.39%

3-Year Change

-128.6%

5-Year Change

-219.97%

15-Year Change

-219.97%

CVAC EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

4.78%
CVAC annual EBITDA is higher than 4.78% of companies in Healthcare sector

High & Low

All-time High

-$79.20 M

3-Year Low

-$457.28 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CVAC previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 24, 2025
CVAC next annual earnings announcement is scheduled for Apr 24, 2025

OtherCVACprofitabilitymetrics:

Annual Revenue

$58.20 M
CVAC annual revenue is $58.20 million

Annual Net Income

-$281.66 M
CVAC annual net profit is -$281.66 million

Annual EBIT

-$278.75 M
CVAC annual earnings before interest & taxes is -$278.75 million

Annual EPS

-$1.28
CVAC annual earnings per share is -$1.28

Quarterly EBITDA

$412.68 M
+$483.70 M+681.03%

September 1, 2024

Summary

Performance

3-Month Change

+681.03%

1-Year Change

+681.03%

3-Year Change

+681.03%

5-Year Change

+681.03%

CVAC Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

95.38%
CVAC quarterly EBITDA is higher than 95.38% of companies in Healthcare sector

High & Low

All-time High

$412.68 M
CVAC quarterly EBITDA is currently at an all-time high

3-Year Low

-$128.74 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CVAC previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Apr 24, 2025
CVAC next earnings announcement is scheduled for Apr 24, 2025

OtherCVACprofitabilitymetrics:

Quarterly Revenue

$543.20 M
CVAC quarterly revenue is $543.20 million

Quarterly Net Income

$371.78 M
CVAC quarterly net profit is $371.78 million

Quarterly EBIT

$407.71 M
CVAC quarterly earnings before interest & taxes is $407.71 million

Quarterly EPS

$1.65
CVAC quarterly earnings per share is $1.65

TTM EBITDA

$186.66 M
+$458.59 M+168.64%

September 1, 2024

Summary

Performance

3-Month Change

+168.64%

1-Year Change

+168.64%

3-Year Change

+168.64%

5-Year Change

+168.64%

CVAC TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.99%
CVAC TTM EBITDA is higher than 87.99% of companies in Healthcare sector

High & Low

All-time High

$186.66 M
CVAC TTM EBITDA is currently at an all-time high

3-Year Low

-$462.20 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CVAC previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Apr 24, 2025
CVAC next earnings announcement is scheduled for Apr 24, 2025

OtherCVACprofitabilitymetrics:

TTM Revenue

$596.48 M
CVAC TTM revenue is $596.48 million

TTM Net Income

$123.72 M
CVAC TTM net profit is $123.72 million

TTM EBIT

$164.44 M
CVAC TTM earnings before interest & taxes is $164.44 million

TTM EPS

$0.55
CVAC TTM earnings per share is $0.55

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$253.43 M
CVAC annual EBITDA is -$253.43 million

Annual Net Income

-$281.66 M
CVAC annual net profit is -$281.66 million

Annual Interest Expense

$2.70 M
CVAC annual interest expense is $2.70 million

Annual Income Tax

$214.40 K
CVAC annual income tax is $214.40 thousand

Annual D&A

$25.32 M
CVAC annual depreciation & amortization is $25.32 million

CVAC EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-8.4%+681.0%+168.6%
3 y3 years-128.6%+681.0%+168.6%
5 y5 years-220.0%+681.0%+168.6%

CVAC EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-8.4%+44.6%at high+420.6%at high+140.4%
5 y5-year-147.4%+44.6%at high+337.6%at high+136.1%
alltimeall time-220.0%+44.6%at high+337.6%at high+136.1%

CureVac NV EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$412.68 M(-681.0%)
$186.66 M(-168.6%)
Jun 2024
-
-$71.02 M(+1.1%)
-$271.93 M(+2.1%)
Mar 2024
-
-$70.25 M(-17.1%)
-$266.29 M(+6.3%)
Dec 2023
-$253.43 M(+8.4%)
-$84.74 M(+84.6%)
-$250.40 M(-14.9%)
Sep 2023
-
-$45.91 M(-29.8%)
-$294.40 M(+1.8%)
Jun 2023
-
-$65.39 M(+20.3%)
-$289.20 M(+4.6%)
Mar 2023
-
-$54.36 M(-57.8%)
-$276.43 M(+21.9%)
Dec 2022
-$233.81 M(-48.9%)
-$128.74 M(+216.3%)
-$226.75 M(+131.6%)
Sep 2022
-
-$40.70 M(-22.6%)
-$97.89 M(-55.2%)
Jun 2022
-
-$52.62 M(+1024.6%)
-$218.54 M(-35.6%)
Mar 2022
-
-$4.68 M(-4361.6%)
-$339.56 M(-26.5%)
DateAnnualQuarterlyTTM
Dec 2021
-$457.28 M(+312.5%)
$109.80 K(-100.1%)
-$462.20 M(-10.7%)
Sep 2021
-
-$161.35 M(-7.1%)
-$517.45 M(+31.1%)
Jun 2021
-
-$173.65 M(+36.4%)
-$394.56 M(+76.0%)
Mar 2021
-
-$127.32 M(+130.9%)
-$224.23 M(+87.9%)
Dec 2020
-$110.86 M(+8.2%)
-$55.14 M(+43.4%)
-$119.36 M(+13.0%)
Sep 2020
-
-$38.46 M(+1059.3%)
-$105.61 M(+21.6%)
Jun 2020
-
-$3.32 M(-85.2%)
-$86.86 M(+4.0%)
Mar 2020
-
-$22.45 M(-45.7%)
-$83.54 M(+0.3%)
Dec 2019
-$102.44 M(+29.3%)
-$41.38 M(+110.0%)
-$83.26 M(+98.8%)
Sep 2019
-
-$19.71 M(-11.1%)
-$41.87 M(+88.9%)
Mar 2019
-
-$22.17 M
-$22.17 M
Dec 2018
-$79.20 M
-
-

FAQ

  • What is CureVac NV annual EBITDA?
  • What is the all time high annual EBITDA for CureVac NV?
  • What is CureVac NV annual EBITDA year-on-year change?
  • What is CureVac NV quarterly EBITDA?
  • What is the all time high quarterly EBITDA for CureVac NV?
  • What is CureVac NV quarterly EBITDA year-on-year change?
  • What is CureVac NV TTM EBITDA?
  • What is the all time high TTM EBITDA for CureVac NV?
  • What is CureVac NV TTM EBITDA year-on-year change?

What is CureVac NV annual EBITDA?

The current annual EBITDA of CVAC is -$253.43 M

What is the all time high annual EBITDA for CureVac NV?

CureVac NV all-time high annual EBITDA is -$79.20 M

What is CureVac NV annual EBITDA year-on-year change?

Over the past year, CVAC annual EBITDA has changed by -$19.62 M (-8.39%)

What is CureVac NV quarterly EBITDA?

The current quarterly EBITDA of CVAC is $412.68 M

What is the all time high quarterly EBITDA for CureVac NV?

CureVac NV all-time high quarterly EBITDA is $412.68 M

What is CureVac NV quarterly EBITDA year-on-year change?

Over the past year, CVAC quarterly EBITDA has changed by +$483.70 M (+681.03%)

What is CureVac NV TTM EBITDA?

The current TTM EBITDA of CVAC is $186.66 M

What is the all time high TTM EBITDA for CureVac NV?

CureVac NV all-time high TTM EBITDA is $186.66 M

What is CureVac NV TTM EBITDA year-on-year change?

Over the past year, CVAC TTM EBITDA has changed by +$458.59 M (+168.64%)